Broker slaps $3.40 share price target on Nanosonics Ltd

The research analysts at sell-side broker Morgans have reportedly been running the ruler over up-and-coming hospital equipment business Nanosonics Ltd (ASX: NAN) and lifted their share price target to $3.40 per share.

Nanosonics manufactures and sells ultrasound probe disinfectant devices and grew unit sales 41% over 2017, with the majority of the sales in the giant U.S. healthcare market.

It is also successfully expanding sales growth in Europe and Asia. Overall, it posted a profit (before an income tax benefit) of $13.9 million on sales of $67.5 million over the year and is reinvesting heavily in developing new products that target the infection control market.

Unfortunately, Nanosonics’ potential is no secret with the company’s current value of $871 million around 62x its trailing profit before income tax which means it needs to deliver several years of strong profit growth to justify today’s valuation.

Notably, it was only back in August 2017 that Morgans reportedly cut its share price target 19% to $2.91 prior to today’s new of an upgrade. This goes to show how sell-side brokerage houses that also have research desks like to chop and change share price targets in order to drum up commissions every time investors trade in response to them. I’d rate the stock a hold for now, although I’m a buyer of it gets much cheaper.

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Cochlear or REA Group.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned.

You can find Tom on Twitter @tommyr345

The Motley Fool Australia owns shares of Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.